D-0754-2021 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0754-2021 was initiated by RemedyRepack Inc. on Aug 17, 2021 and is designated Class II. Reason for recall: A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. Product was repackaged into 180 count bottles. The recall status is terminated (terminated Mar 9, 2022). Affected quantity: 4.

Recall details

Product Type
Drugs
Report Date
Sep 1, 2021
Initiation Date
Aug 17, 2021
Termination Date
Mar 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4

Product description

Carvedilol 25 mg, 180-count bottle, Rx only, Manufactured by Zydus Pharm, Pennington, NJ 08534, NDC 68382-0095-05, Repackaged by RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1826-01

Reason for recall

A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. Product was repackaged into 180 count bottles.

Distribution pattern

Product was distributed to two medical facilities in VA and FL.

Code information

Lot # B1273286-071521, Exp 07/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0754-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0754-2021. Report a data issue: hello@regdatalab.com.